跳至主要内容
临床试验/NCT05728918
NCT05728918已完成不适用

Effectiveness of Antrodia Cinnamomea Mycelia on Improving Immune Response in Subhealth People

Greenyn Biotechnology Co., Ltd.2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2023年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
25
试验地点
2
主要终点
Immune analysis

研究概览

简要总结

This study aims to assess the effect of Antrodia cinnamomea mycelia on immune modulation in subhealth people.

详细描述

This study aims to assess the effect of Antrodia cinnamomea mycelia on immune modulation in subhealth people: a randomized, double-blind, placebo-controlled, and parallel clinical investigation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
50 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects are easy to feel fatigued
  • Subjects have poor sleep quality

排除标准

  • Pregnant women or preparing for pregnancy.
  • Lactating women.
  • Women gave birth 6 months before the study.
  • Poor kindy and livers funcitons
  • Severe cardiovascular or other chronic diseases
  • Alcohol abuser
  • Using immune-associated supplements

结局指标

主要结局

Immune analysis

时间窗: Baseline up to 4 weeks

Changes in T cell markers of 29 participants will be analyzed between baseline and week 4.

Antibody analysis

时间窗: Baseline up to 4 weeks

Changes in IgA levels of 29 participants will be analyzed between baseline and week 4.

Cytokine analysis

时间窗: Baseline up to 4 weeks

Changes in IL-1beta levels of 29 participants will be analyzed between baseline and week 4.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验